Clarifying the Facts: Understanding Pennsylvania’s False Claims Act

Pennsylvania’s existing Medicaid fraud prevention system is working effectively, despite renewed pressure to pass a state-specific False Claims Act (FCA) during budget negotiations, according to civil justice reform advocates and policy experts.

The state is currently embroiled in its annual budget season, with lawmakers searching for revenue sources that won’t require tax increases. Among the proposals gaining attention is the implementation of a Pennsylvania-specific False Claims Act, which would allow private individuals to file lawsuits against businesses and healthcare providers suspected of Medicaid fraud.

Proponents suggest the measure could generate significant revenue for the state by recovering misspent Medicaid funds. Recent news articles have questioned why Pennsylvania hasn’t already adopted such legislation, noting that other states have recovered millions through similar laws.

However, critics of the proposal point out that Pennsylvania already benefits from the federal False Claims Act without incurring additional costs. Under the current federal system, Pennsylvania receives its full share of any Medicaid fraud recoveries without having to pay the private plaintiffs (known as “relators”) who initiate these cases. The relators’ compensation—which can reach up to 30 percent of recoveries—comes solely from the federal portion.

If Pennsylvania were to implement its own FCA, relators would become eligible for an additional payment from the state’s portion of recoveries, effectively reducing the net amount Pennsylvania receives from Medicaid fraud cases.

The Commonwealth currently maintains one of the nation’s lowest Medicaid error rates at just 2.5 percent, suggesting existing fraud prevention mechanisms are functioning effectively. The Attorney General’s office already possesses tools to investigate and prosecute fraudulent Medicaid activity without outsourcing these responsibilities to private attorneys.

Small businesses and rural healthcare providers could face particularly severe consequences under a state FCA. The proposed penalties—including triple damages and fines of up to $28,000 per claim—could potentially bankrupt smaller entities that make coding errors, even without fraudulent intent. Critics argue this creates a coercive “sue and settle” environment where defendants feel compelled to settle claims regardless of merit to avoid financial ruin.

The claims of immediate financial windfall also appear exaggerated when examining other states’ experiences. New York has recovered approximately $4 billion since implementing its state FCA in 2011, while California has recovered around $3 billion since 2000, and Minnesota about $60 million since 2010. While these are substantial sums, they accumulated over many years rather than materializing within a single budget cycle as some Pennsylvania proponents suggest.

Some supporters have claimed a state FCA could deliver $3 billion to Pennsylvania, potentially closing half the current budget deficit. However, historical data from other states contradicts this timeline, showing recoveries typically accumulate gradually over many years.

Critics characterize the push for a state FCA as primarily benefiting trial lawyers rather than state coffers. They argue the legislation would expand liability and create new opportunities for attorneys to pursue cases against the private sector for significant financial gain, while potentially damaging Pennsylvania’s healthcare infrastructure and small business community.

The debate highlights the tension between enhancing fraud recovery mechanisms and protecting healthcare providers and businesses from potentially excessive litigation. As budget negotiations continue, lawmakers must weigh these competing concerns while evaluating the actual revenue potential of a state False Claims Act against its broader economic impact on Pennsylvania’s healthcare system and business environment.